Determination of tissue polypeptide-specific antigen in pleural fluid and serum from patients with pleural effusion
- PMID: 8551059
- DOI: 10.1177/172460089501000306
Determination of tissue polypeptide-specific antigen in pleural fluid and serum from patients with pleural effusion
Abstract
As a tool for differentiating malignant and benign pleural effusions, we evaluated the diagnostic value of the assay of tissue polypeptide-specific antigen (TPS) in pleural fluid and serum, and of the pleural fluid TPS/serum TPS ratio in patients with pleural effusion. We studied prospectively 147 consecutive patients who had pleural effusions: 43 malignant pleural effusions and 104 benign pleural effusions. TPS levels were measured by RIA. The sensitivity and specificity of these measurements were: TPS in pleural fluid (cutoff 20,000 U/L): 0.21 and 0.98; TPS in serum (cutoff 300 U/L); 0.31 and 0.96; pleural fluid TPS/serum TPS ratio (cutoff 1200): 0.07 and 0.99. All these values enhanced the sensitivity of cytologic analysis of pleural fluid. However, we conclude that TPS assay in pleural fluid and serum, and the pleural fluid TPS/serum TPS ratio have limited diagnostic value in patients with pleural effusion.
Similar articles
-
Diagnostic value of soluble receptor-binding cancer antigen expressed on SiSo cells and carcinoembryonic antigen in differentiating malignant from benign pleural effusion.Tumour Biol. 2016 Mar;37(3):3257-64. doi: 10.1007/s13277-015-4174-8. Epub 2015 Oct 5. Tumour Biol. 2016. PMID: 26438059
-
Diagnostic utility of CYFRA 21-1, carcinoembryonic antigen, CA 125, neuron specific enolase, and squamous cell antigen level determinations in the serum and pleural fluid of patients with pleural effusions.Cancer. 1999 Oct 15;86(8):1488-95. doi: 10.1002/(sici)1097-0142(19991015)86:8<1488::aid-cncr15>3.0.co;2-y. Cancer. 1999. PMID: 10526277
-
Diagnostic value of tumor markers for differentiating malignant and benign pleural effusions of Iranian patients.Pathol Oncol Res. 2005;11(4):236-41. doi: 10.1007/BF02893857. Epub 2005 Dec 31. Pathol Oncol Res. 2005. PMID: 16388321
-
[Contribution of pleural fluid analysis to the diagnosis of pleural effusion].Med Clin (Barc). 2015 Aug 21;145(4):171-7. doi: 10.1016/j.medcli.2014.08.005. Epub 2014 Nov 27. Med Clin (Barc). 2015. PMID: 25433793 Review. Spanish.
-
Differentiating between malignant and idiopathic pleural effusions: the value of diagnostic procedures.QJM. 2007 Jun;100(6):351-9. doi: 10.1093/qjmed/hcm032. QJM. 2007. PMID: 17525131 Review.
Cited by
-
Pleural biomarkers in diagnostics of malignant pleural effusion: a narrative review.Transl Lung Cancer Res. 2021 Mar;10(3):1557-1570. doi: 10.21037/tlcr-20-1111. Transl Lung Cancer Res. 2021. PMID: 33889529 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials